1.
Disease | n | Gender | Virus-positive donor | GPC3 (ng/mL) | GPC3 positive rate | |||
Male | Female | HBV | HCV | |||||
Compared with the other groups, *P < 0.05; Compared with the other groups, ΔP < 0.05. | ||||||||
PHC | 60 | 42 | 18 | 42 | 3 | 21.67±19.36* | 39/60 (65%) | |
Metastatic liver cancer | 60 | 35 | 25 | 5 | 0 | 5.15±4.45Δ | 7/60 (11.7%) | |
Liver cirrhosis | 50 | 36 | 14 | 32 | 4 | 4.27±3.36Δ | 3/50 (6%) | |
Chronic viral hepatitis | 50 | 31 | 19 | 40 | 10 | 3.96±3.60Δ | 4/50 (8%) | |
Hepatic cyst | 20 | 13 | 7 | 4 | 0 | 2.55±1.22 | 1/20 (5%) | |
Adiposis hepatica | 20 | 12 | 8 | 0 | 0 | 2.54±1.22 | 0/20 (0%) | |
Hepatic hemangioma | 20 | 10 | 10 | 0 | 0 | 2.55±1.15 | 0/20 (0%) | |
Drug-induced hepatitis | 20 | 10 | 0 | 0 | 0 | 1.92±1.10 | 0/20 (0%) | |
Healthy control | 40 | 22 | 18 | 0 | 0 | 1.68±0.94 | 0/40 (0%) |